Class: Postbiotic
Format: Powder
Pylopass™
Novonesis' Pylopass™ is a postbiotic that supports the reduction of H. pylori, common bacteria that can damage the lining of the stomach. Clinical studies have shown that consuming Pylopass™ may lead to reduced symptoms of gastric inflammation, potentially supporting a healthy microbiome and microbial balance.
Product features, details and benefits
- Supports reduction of H. pylori in the stomach
- May reduce symptoms of gastric inflammation
- Supports a healthy microbiome and microbial balance
Pylopass™ postbiotic is based on the species Limosilactobacillus reuteri (formerly known as Lactobacillus reuteri).
The strain has QPS status in the EU (Qualified Presumption of Safety) and GRAS (Generally Recognized as Safe) status in the US.
Pylopass™ is not available in all markets.
This product contains microbials. While microbial products are safe to use in consumer applications, they must be handled correctly in production environments to ensure that workers do not inhale organic dust and bioaerosols.
Please follow the precautionary handling recommendations below:
- Avoid breathing dust/fume/gas/mist/vapors/spray
- Avoid contact with eyes, skin, or clothing
- In case of inadequate ventilation wear respiratory protection
- IF INHALED: Remove person to fresh air and keep comfortable for breathing
- Store in a dry place. Store in a closed container
- Dispose of contents/containers in accordance with local regulations
For recommendations on how to safely handle the microbial product, please visit the guide.
Get in touch
Fill out the form below and one of our experts will contact you shortly.
One more step…
To complete the get in touch form or sign up, please click on the button below to enable cookies.
Disclaimer
This content is intended exclusively for business-to-business purposes for a professional audience only and is not intended to target consumers.